Idexx Laboratories (IDXX) Q1 2024 Earnings
Idexx Laboratories reported Q1 2024 revenue of $964.1M, missed analyst consensus of $964.4M by $317.2K. Diluted EPS came in at $2.81, beat the $2.67 consensus by $0.14. Idexx Laboratories reports across 3 business segments, led by Companion Animal Group (CAG), Water Quality Products, and Livestock, Poultry and Dairy (LPD).
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Idexx Laboratories's Q1 2024 earnings report.
Idexx Laboratories (IDXX) reported Q1 2024 earnings on May 1, 2024 before market open.
Idexx Laboratories reported revenue of $964.1M and diluted EPS of $2.81 for Q1 2024.
Revenue missed the consensus estimate of $964.4M by $317.2K. EPS beat the consensus estimate of $2.67 by $0.14.
You can read the 10-Q periodic report (0000874716-24-000083) directly on SEC EDGAR. The filing index links above go to sec.gov.